145 related articles for article (PubMed ID: 29205633)
1. A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties.
Busby J; Murray L; Mills K; Zhang SD; Liberante F; Cardwell CR
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):78-86. PubMed ID: 29205633
[TBL] [Abstract][Full Text] [Related]
2. A systematic assessment of the association between frequently prescribed medicines and the risk of common cancers: a series of nested case-control studies.
McDowell RD; Hughes C; Murchie P; Cardwell C
BMC Med; 2021 Jan; 19(1):22. PubMed ID: 33494748
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
[TBL] [Abstract][Full Text] [Related]
4. Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink.
Murray LJ; Cooper JA; Hughes CM; Powe DG; Cardwell CR
Breast Cancer Res; 2014 Apr; 16(2):R34. PubMed ID: 24708725
[TBL] [Abstract][Full Text] [Related]
5. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
Calip GS; Yu O; Elmore JG; Boudreau DM
Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant medication use and breast cancer risk.
Cotterchio M; Kreiger N; Darlington G; Steingart A
Am J Epidemiol; 2000 May; 151(10):951-7. PubMed ID: 10853633
[TBL] [Abstract][Full Text] [Related]
7. Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.
Pottegård A; Lash TL; Cronin-Fenton D; Ahern TP; Damkier P
Br J Clin Pharmacol; 2018 Sep; 84(9):2152-2161. PubMed ID: 29858518
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study.
Hálfdánarson ÓÖ; Fall K; Ogmundsdottir MH; Lund SH; Steingrímsson E; Ogmundsdottir HM; Zoega H
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):471-478. PubMed ID: 30565786
[TBL] [Abstract][Full Text] [Related]
9. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
10. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
11. Use of case-time-control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly.
Price SD; Holman CD; Sanfilippo FM; Emery JD
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1159-70. PubMed ID: 23797984
[TBL] [Abstract][Full Text] [Related]
12. Risk of breast cancer in symptomatic women in primary care: a case-control study using electronic records.
Walker S; Hyde C; Hamilton W
Br J Gen Pract; 2014 Dec; 64(629):e788-93. PubMed ID: 25452544
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer.
Monsees GM; Malone KE; Tang MT; Newcomb PA; Li CI
J Natl Cancer Inst; 2011 Dec; 103(23):1752-60. PubMed ID: 22021667
[TBL] [Abstract][Full Text] [Related]
14. The contribution of pharmacoepidemiology to the antidepressant-suicidality debate in children and adolescents.
Bridge JA; Axelson DA
Int Rev Psychiatry; 2008 Apr; 20(2):209-14. PubMed ID: 18386214
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant medication use and breast cancer risk.
Wernli KJ; Hampton JM; Trentham-Dietz A; Newcomb PA
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):284-90. PubMed ID: 19226540
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceuticals that cause mammary gland tumors in animals: findings in women.
Friedman GD; Jiang SF; Udaltsova N; Chan J; Quesenberry CP; Habel LA
Breast Cancer Res Treat; 2009 Jul; 116(1):187-94. PubMed ID: 18629631
[TBL] [Abstract][Full Text] [Related]
17. Generalisability of pharmacoepidemiological studies using restricted prescription data.
Brown C; Barron TI; Bennett K; MacDonald D; Dwane F; Sharp L
Ir J Med Sci; 2016 Aug; 185(3):723-727. PubMed ID: 26443746
[TBL] [Abstract][Full Text] [Related]
18. Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007.
Lind JN; Tinker SC; Broussard CS; Reefhuis J; Carmichael SL; Honein MA; Olney RS; Parker SE; Werler MM;
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):783-93. PubMed ID: 23620412
[TBL] [Abstract][Full Text] [Related]
19. Using nationally representative survey data for external adjustment of unmeasured confounders: An example using the NHANES data.
Hernández-Díaz S; Bateman BT; Palmsten K; Schneeweiss S; Huybrechts KF
Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1151-1158. PubMed ID: 31863536
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant medication use and breast cancer risk: a case-control study.
Steingart A; Cotterchio M; Kreiger N; Sloan M
Int J Epidemiol; 2003 Dec; 32(6):961-6. PubMed ID: 14681256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
